We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

VEDA LAB

VEDALAB focuses on the development, production and marketing of in vitro immunodiagnostic reagents and instruments. I... read more Featured Products: More products

Download Mobile App





Vedalab Presents Wide Range of Quantitative Rapid Tests

By LabMedica International staff writers
Posted on 13 Nov 2023
Print article
Image: Vedalab is exhibiting at MEDICA 2023 at booth number n°1A64, Hall 1 (Photo courtesy of Vedalab)
Image: Vedalab is exhibiting at MEDICA 2023 at booth number n°1A64, Hall 1 (Photo courtesy of Vedalab)

Vedalab (Cerisé, France) is presenting its wide range of lateral flow qualitative rapid tests and rapid tests for home use alongside its new generation rapid test reader at MEDICA 2023.

Vedalab offers several rapid tests for drugs of abuse detection (one drug/test) for home use including cannabinoid, cocaine, opiates, amphetamines and methamphetamines. These tests are to be used with urine samples. Vedalab also offers an immunochromatographic rapid test for the qualitative detection of respiratory syncytial virus (RSV) and influenza A and B viruses in nasal or nasopharyngeal swab samples. This is in addition to its immunochromatographic rapid test for the quantitative detection of anti-spike (S1) IgM and IgG antibodies to SARS-CoV-2 virus in human whole blood, plasma, or serum samples. When used in combination with the VEDALAB Easy reader+ instrument, it can detect and quantify IgM and IgG antibodies to the spike SARS-CoV-2 protein produced after virus infection in human serum, plasma, or finger prick whole blood samples.

At MEDICA 2023, Vedalab is demonstrating the Easy reader+ POC reader that allows quantitative measurements from fingerprick whole blood samples using rapid lateral flow tests. The instrument includes the most advanced and up-to-date technologies (touch screen, enhanced memory, and internet upgrading). The quantitative lateral flow immunochromatography analyzer is intended to provide a quantitative immunochromatography assay result for a wide range of otherwise purely qualitative rapid test devices to increase the accuracy and efficiency of the home, point of care, and laboratory testing of the relevant marker analytes.

Related Links:
Vedalab 

Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Silver Member
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Centromere B Assay
Centromere B Test

Print article

Channels

Clinical Chemistry

view channel
Image: The study demonstrated that electric-field molecular fingerprinting can probe cancer (Photo courtesy of ACS Central Science, 2025, 10.1021/acscentsci.4c02164)

New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma

Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read more

Molecular Diagnostics

view channel
Image: The study validated the Lumipulse p-tau21 automated and scalable blood test system (Photo courtesy of Fujirebio)

Blood Test for Early Alzheimer's Detection Achieves Over 90% Accuracy

Alzheimer's disease (AD) is a debilitating condition and a leading cause of disability and death worldwide. The availability of reliable diagnostic tools is currently restricted, and diagnosis often relies... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.